Literature DB >> 30213256

Pseudobulbar affect after stroke: a narrative review.

Tarun Girotra1, Forrest Lowe1, Wuwei Feng1.   

Abstract

BACKGROUND: Pseudobulbar affect (PBA) is a neuropsychological condition of emotional lability and affective dysregulation associated with a variety of neurological conditions such as stroke, traumatic brain disease, and neurodegenerative disease. The true prevalence and medico-social burden of PBA associated with stroke is unclear. Often confused with post-stroke mood disorders, PBA is under-recognized and under-treated.
OBJECTIVE: To provide a comprehensive narrative synthesis of published literature on the topic of PBA.
METHODS: Literature review was performed by searching the key words "pseudobulbar atrophy", "emotional incontinence," and "stroke" in PubMed. Only manuscripts published in English were appraised and relevant content was extracted, synthesized, and summarized.
RESULTS: A narrative overview was performed on the following topics: epidemiology, pathophysiology, clinical features of differential diagnosis, impact on public health, and therapeutic options.
CONCLUSION: PBA remains an under-treated condition with significant psychosocial burden on both effected stroke survivors and their families. Advances have been made in developing consensus-based clinical diagnostic criteria for PBA. Early identification and prompt initiation of therapeutic measures are required in these stroke patients. Further research is needed to develop better PBA diagnostic criteria and more cost-effective therapeutic treatment options.

Entities:  

Keywords:  Stroke; clinical presentation; emotion incontinence; epidemiology; pathophysiology; pseudobulbar affect; treatment

Year:  2018        PMID: 30213256     DOI: 10.1080/10749357.2018.1499300

Source DB:  PubMed          Journal:  Top Stroke Rehabil        ISSN: 1074-9357            Impact factor:   2.119


  1 in total

1.  Pseudobulbar Affect Presenting as Aggressive Behavior.

Authors:  Sana Elham Kazi; Adeel Anwar
Journal:  Cureus       Date:  2022-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.